Compare Moderna, Inc. (MRNA) vs Shell PLC (SHEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Shell PLC — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Shell PLC trades at $86.69 (market cap $235.24B). The key difference: Shell PLC is far larger — about 10× Moderna, Inc.'s market cap, and Shell PLC pays a 3.63% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | SHEL | |
|---|---|---|
Market Cap | $23.60B | $235.24B |
Sector | Health | Energy |
52-Week High | $81.80 | $94.15 |
52-Week Low | $22.36 | $70.31 |
Enterprise Value | $19.70B | $287.77B |
Dividend Yield | — | 3.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Shell PLC
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →
